AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/β-Catenin Signaling Activity

por Kwan, H. T., Chan, David W., Cai, Patty C. H., Mak, Celia S. L., Yung, Mingo M. H., Leung, Thomas H. Y., Wong, Oscar G. W., Cheung, Annie N. Y., Ngan, Hextan Y. S.
Publicado 2013

Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells

por Chan, David W., Hui, Winnie W. Y., Cai, Patty C. H., Liu, Michelle X., Yung, Mingo M. H., Mak, Celia S. L., Leung, Thomas H. Y., Chan, Karen K. L., Ngan, Hextan Y. S.
Publicado 2012

MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis

por Mak, Celia S. L., Yung, Mingo M. H., Hui, Lynn M. N., Leung, Leanne L., Liang, Rui, Chen, Kangmei, Liu, Stephanie S., Qin, Yiming, Leung, Thomas H. Y., Lee, Kai-Fai, Chan, Karen K. L., Ngan, Hextan Y. S., Chan, David W.
Publicado 2017

Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis

por Mo, Yulan, Leung, Leanne L., Mak, Celia S. L., Wang, Xueyu, Chan, Wai-Sun, Hui, Lynn M. N., Tang, Hermit W. M., Siu, Michelle K. Y., Sharma, Rakesh, Xu, Dakang, Tsui, Stephen K. W., Ngan, Hextan Y. S., Yung, Mingo M. H., Chan, Karen K. L., Chan, David W.
Publicado 2023